Aoki
Aoki v. Gilbert
Opinion
trial_court Opinion
1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10 11 THOMAS T. AOKI, M.D.; AOKI No. 2:11-cv-02797-TLN-CKD DIABETES RESEARCH INSTITUTE, a 12 California Non-Profit Corporation, 13 Plaintiff, FINDINGS OF FACT AND
CONCLUSIONS OF LAW
14 v. 15 GREGORY FORD GILBERT; BIONICA INC., a Nevada Corporation; et al., 16 Defendants. 17
18 19 On October 24, 2011, Plaintiffs Thomas T. Aoki, M.D. (“Dr. Aoki”), and Aoki Diabetes 20 Research Institute (“ADRI”) (collectively, “Plaintiffs”) initiated the above-captioned action. 21 (ECF No. 1.) On April 2, 2013, Plaintiffs filed a First Amended Complaint asserting, inter alia, 22 causes of action for patent infringement, copyright infringement, false and misleading advertising 23 under federal and California law, and unfair competition under federal and California law against 24 numerous defendants, of which the following remain (“Defendants”): Gregory Ford Gilbert; 25 Bionica Inc. (“Bionica”); Bionica Int’l, LLC1; Trina Health, LLC (“Trina” or “Trina Health”); 26 1 The FAC names Bionica Int.’l, LLC, a California limited…